The impact of smoking on anti-COVID antibody titers after vaccination: anarrative review in some Asian countries

According to ۲۰۱۹ worldwide statistics, there were more than ۱ billion tobacco smokers, makingsmoking one of the top significant preventable causes of disease and early death. Smoking poses aconsiderable problem to healthcare systems throughout the world. The coronavirus outbreak,which is now sweeping the world, is causing much concern. Since December ۲۰۲۰, severalCOVID-۱۹ vaccines have been produced and approved, and an efficient immunologic response tovaccination is essential to limiting the pandemic"s harmful health effects. According to several ofthese research, smokers" vaccine antibody titers are lower or decline more quickly thannonsmokers. Thus, this narrative review article is conducted with the aim of finding the impact ofsmoking on anti-SARS-CoV-۲ IgG antibody titers after COVID vaccination in some Asiancountries including China, Japan, Jordan, and Turkey. Relevant English publications from the Webof Science, PubMed, Scopus, and Google Scholar using keywords such as COVID-۱۹, smoking,vaccination, China, Japan, Jordan, and Turkey Were searched and extracted. This review revealedthat smoking is one of the significant risk factors for COVID-۱۹ infection that emerges aftervaccination. Present smoking promotes lower antibody titers and quitting smoking beforeimmunization would increase the ability to respond to the vaccine. Moreover, cigarette smokingand using of tobacco products could be predictors of a reduced immunological response to theCOVID-۱۹ vaccination. To develop a more individualized strategy for vaccination additionalresearch on the relationships between Ab titers and the thorough histories of people like smokinghistory is required.

کلیدواژه ها:

COVID-۱۹ ، Smoking ، Vaccination ، China ، Japan ، Jordan ، Turkey